Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

Model Context Protocol-based agentic integration allows for faster, more accurate access and usage of data and information to reduce errors and elevate productivity ...

Small- and mid-cap AI plays - PATH, FIVN, QLYS, TDC and BB lagged last year but could become game changers in 2026 as AI infrastructure demand stays bullish.

The American robotics industry enters 2026 riding an unprecedented wave of commercial breakthroughs, venture capital, and FDA approvals that position the United States at the forefront of global ...

Learn more about whether Adeia Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Level up your career in 2026 by mastering automation skills with the best courses and certifications for real-world demand ...

Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

UiPath's AI-driven automation momentum, strong cash position and enterprise adoption stand out against Microvast's growth, losses and liquidity strain.

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.